HLF
HERBALIFE LTD.
Research: Finviz ↗·Perplexity ↗
No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.
News Summary
NeutralHerbalife delivered Q3 2026 earnings that beat expectations with 6.0% net sales growth (fifth consecutive quarter of expansion) and announced a $250M share repurchase program, but the CEO transition—with founder-era CEO Stephan Gratziani exiting effective October 31, 2026, and CFO John DeSimone assuming interim CEO role—introduces near-term leadership uncertainty during a period of operational momentum.
Red flags
- •CEO departure effective October 31, 2026, with interim CFO replacement creating leadership vacuum
- •Zacks downgrade from 'strong-buy' to 'hold' in late October, indicating analyst skepticism despite earnings beat
- •Interim CEO arrangement suggests search for permanent replacement may be ongoing, creating extended uncertainty
Fund 13D/13G Filings (1)
Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).
| Fund | Form | ∆ Shares | % of Class | Since Filing | Filed | Src |
|---|---|---|---|---|---|---|
| Baupost Group | SC 13G/A | — | 9.8% | +2.7% vs SPY -2.4% abs | 2026-11-13 | ↗ |